The long-term durability of cytogenetic responses in patients with accelerated phase chronic myeloid leukemia treated with imatinib 600 mg: the GIMEMA CML Working Party experience after a 7-year follow-up.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples